Research ArticleSpecial Contribution
Proceedings: PET Drugs—A Workshop on Inspections Management and Regulatory Considerations
Sue Bunning, Christopher Ignace, Steve Mattmuller, Sally W. Schwarz, Peter J.H. Scott, Henry F. VanBrocklin, Steven S. Zigler and on behalf of the Coalition of Drug Manufacturers
Journal of Nuclear Medicine July 2022, 63 (7) 1117-1123; DOI: https://doi.org/10.2967/jnumed.121.263443
Sue Bunning
1Medical Imaging and Technology Alliance, Arlington, Virginia;
Christopher Ignace
2Cardinal Health, Dublin, Ohio;
Steve Mattmuller
3Kettering Medical Center, Kettering, Ohio;
Sally W. Schwarz
4Department of Radiology, Washington University School of Medicine, St. Louis, Missouri;
Peter J.H. Scott
5Department of Radiology, University of Michigan, Ann Arbor, Michigan;
Henry F. VanBrocklin
6University of California San Francisco, San Francisco, California; and
Steven S. Zigler
7Siemens PETNET Solutions, Knoxville, Tennessee
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 63, Issue 7
July 1, 2022
Proceedings: PET Drugs—A Workshop on Inspections Management and Regulatory Considerations
Sue Bunning, Christopher Ignace, Steve Mattmuller, Sally W. Schwarz, Peter J.H. Scott, Henry F. VanBrocklin, Steven S. Zigler, on behalf of the Coalition of Drug Manufacturers
Journal of Nuclear Medicine Jul 2022, 63 (7) 1117-1123; DOI: 10.2967/jnumed.121.263443
Proceedings: PET Drugs—A Workshop on Inspections Management and Regulatory Considerations
Sue Bunning, Christopher Ignace, Steve Mattmuller, Sally W. Schwarz, Peter J.H. Scott, Henry F. VanBrocklin, Steven S. Zigler, on behalf of the Coalition of Drug Manufacturers
Journal of Nuclear Medicine Jul 2022, 63 (7) 1117-1123; DOI: 10.2967/jnumed.121.263443
Jump to section
- Article
- Abstract
- OPENING REMARKS
- SESSION I: CONSIDERATIONS AND TRENDS IN INSPECTIONS AND COMPLIANCE
- SESSION II: LIFE CYCLE MANAGEMENT OF PET DRUG APPLICATIONS
- SESSION III: CHEMISTRY AND PRODUCT QUALITY ASSURANCE
- SESSION IV: CHANGING LANDSCAPE OF PET DRUGS, LABELING REQUIREMENTS, AND ELECTRONIC FILING REQUIREMENTS
- CLOSING REMARKS
- DISCUSSION: WORKSHOP SUMMARY AND RECOMMENDATIONS FROM PET MANUFACTURING STAKEHOLDERS
- CONCLUSION
- DISCLOSURE
- ACKNOWLEDGMENTS
- Footnotes
- REFERENCES
- Figures & Data
- Supplemental
- Info & Metrics
Related Articles
Cited By...
- No citing articles found.